Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions - 14/04/20
Funding sources: Haley Naik is supported by the National Institutes of Health (K23AR0745310). Eleni Linos is supported by the National Institutes of Health (DP2CA225433 and K24AR075060). |
|
Conflicts of interest: Dr Naik has received grant support from AbbVie and consulting fees from 23andMe; however, there is no conflict with the present study. Dr Naik is a Hidradenitis Suppurativa Foundation Board Member. Drs Wehner, Micheletti, Noe, Linos, and Margolis have no conflicts of interest to declare. |
|
IRB approval status: Institutional Review Board approval was exempted for this study. |
|
Reprints not available from the authors. |
Vol 82 - N° 5
P. 1239-1241 - mai 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?